Medsena - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 81,552 | 35,337 | 17,580 | 77,811 | 71,303 | 78,706 | 21,394 | 20,397 |
| Profit before tax | 27,960 | 2,389 | -10,734 | 9,563 | 1,894 | 18,780 | 2,909 | -11,835 |
| Net profit | 26,550 | 2,206 | -10,734 | 9,039 | 1,758 | 17,837 | 2,762 | -11,835 |
| Equity | 24,414 | 23,620 | 11,386 | 20,425 | 20,183 | 31,963 | 29,781 | 15,946 |
| Liabilities | - | - | - | - | 6,580 | 8,715 | 899 | 528 |
| Non-current assets | 28,489 | 27,582 | 21,157 | 15,950 | 9,998 | 3,573 | 1,537 | 805 |
| Current assets | 11,595 | 14,540 | 3,989 | 18,610 | 21,166 | 37,105 | 29,143 | 15,669 |
| Total assets | 40,084 | 42,122 | 25,146 | 34,560 | 31,164 | 40,678 | 30,680 | 16,474 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 6,447 | 8,762 | 835 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +3172.6% | -56.7% | -50.3% | +342.6% | -8.4% | +10.4% | -72.8% | -4.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 66.2% | 5.2% | -42.7% | 26.2% | 5.6% | 43.8% | 9.0% | -71.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 108.7% | 9.3% | -94.3% | 44.3% | 8.7% | 55.8% | 9.3% | -74.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 32.6% | 6.2% | -61.1% | 11.6% | 2.5% | 22.7% | 12.9% | -58.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 34.3% | 6.8% | -61.1% | 12.3% | 2.7% | 23.9% | 13.6% | -58.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.3 | 0.3 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 35,337 | 17,580 | 51,874 | 71,303 | 78,706 | 21,394 | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medsena - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 64.79 |
| 2026-06-02 | 2026-06-30 | 23.35 |
| 2025-10-01 | 2025-10-31 | 72.45 |
| 2025-09-02 | 2025-09-30 | 6.60 |
| 2025-07-01 | 2025-07-31 | 61.70 |
| 2025-05-04 | 2025-05-31 | 66.80 |
| 2025-02-01 | 2025-02-28 | 69.45 |
| 2024-12-03 | 2024-12-31 | 62.50 |
| 2024-10-01 | 2024-10-31 | 3.50 |
| 2024-09-03 | 2024-09-30 | 59.00 |
| 2024-08-01 | 2024-08-31 | 64.50 |
| 2023-12-01 | 2023-12-06 | 43.94 |
| 2023-06-01 | 2023-06-07 | 57.46 |
| 2023-01-25 | 2023-01-31 | 99.01 |
| 2023-01-17 | 2023-01-24 | 99.61 |
| 2023-01-03 | 2023-01-04 | 99.61 |
| 2022-12-16 | 2023-01-02 | 48.66 |
| 2022-12-01 | 2022-12-07 | 48.66 |
Medsena - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-30 | 2026-08-25 | 0.04 |
| 2025-07-31 | 2025-08-22 | 0.04 |
| 2025-07-28 | 2025-07-29 | 21.0 |
| 2025-02-01 | 2025-02-07 | 0.28 |
| 2025-01-30 | 2025-01-31 | 429.22 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medsena, MB (company code 304542930) is a small partnership engaged in landscape service activities. In 2025, the company generated revenue of €20.4K, slightly below €21.4K in 2024 and well below €78.7K in 2023, showing a clear two-year decline in turnover. Profitability weakened significantly in 2025: net loss reached €11.8K, compared with net profit of €2.8K in 2024 and €17.8K in 2023. The 2025 profit margin was -58.0%, reflecting the pressure from the lower revenue base and a negative bottom line. Balance sheet size also contracted, with total assets falling to €16.5K from €30.7K a year earlier and €40.7K in 2023. Equity decreased to €15.9K, while liabilities remained limited at €528, leaving an equity ratio of 96.8% and a debt-to-equity ratio of 0.03. Asset turnover stood at 1.24x in 2025, indicating moderate use of assets to generate sales. Return on equity and return on assets were both negative in 2025, consistent with the loss-making year.